Form 8-K: Officer/Director Departure

Charles J. Dockendorff will not stand for re-election at Haemonetics Corporation's 2026 Annual Meeting of Shareholders. He has served on the Board of Directors since 2014 and is a member of the Audit Committee and the Governance and Compliance Committee. Mr. Dockendorff will continue in his roles until the annual meeting. His decision is not due to any disagreement with the Company. The filing also notes the company's principal executive offices and stock exchange information.